WHO Prequalification Landscape Analysis: Trends, Competition & Market Gaps

By abhishek.verma75000 · April 11, 2026

Analysis of WHO prequalified pharmaceutical products highlighting top applicants, growth trends, therapeutic distribution, and market concentration.…

The analysis identified the top 10 applicants with the most WHO prequalified pharmaceutical products. A horizontal bar chart has been generated showing each applicant ranked by their product count, with color intensity indicating the number of products.

Since 2002, a total of 572 products have been prequalified. The bar chart shows how prequalification activity has evolved year by year, with a clear peak in 2020 when 52 products were prequalified — the highest single-year count on record.

The analysis successfully produced two visualizations and a data table showing how prequalified products are distributed across different therapeutic areas. A bar chart displays the count of products per therapeutic area, while a pie chart illustrates each area's percentage share of the total product portfolio.

The analysis produced a horizontal bar chart and data tables showing the most commonly prequalified dosage forms across all products. The chart ranks dosage forms by frequency, making it easy to compare which forms dominate the prequalification landscape.

The distribution of products by Basis of Listing category has been visualized through a pie chart and a bar chart, along with a supporting data table. These visuals clearly show how products are spread across the different listing categories, including their counts and percentage shares.

The analysis shows how many new applicants entered the WHO Prequalification Program each year, based on each applicant's earliest prequalification date. A bar chart and supporting data tables have been generated to visualize the yearly breakdown of new entrants into the program.

The analysis produced two bar charts and supporting data tables comparing the two product types. The first chart shows the volume (number of products) for each product type side by side, and the second chart breaks down how each product type is distributed across different therapeutic areas. Together, these visuals give a clear picture of which product type dominates in quantity and which therapeutic areas each type covers.

The analysis identified the fastest growing therapeutic areas in prequalifications over the last five years. Two charts were generated: a horizontal bar chart ranking the top 10 therapeutic areas by growth rate, and a line chart showing year-by-year prequalification trends for the top 5 fastest growing areas. These visuals make it easy to spot which areas have accelerated most rapidly in recent years.

The analysis reveals how applicants distribute their products across therapeutic areas. Two charts were generated: a scatter plot showing the top 30 applicants by product count plotted against their number of therapeutic areas, and a bar chart breaking down applicants into three categories — Specialists (1 area), Moderate (2–3 areas), and Diversified (4+ areas). The scatter plot uses color coding to make it easy to spot which major applicants concentrate in a single area versus those spreading across many. The bar chart gives an overall count of how many applicants fall into each specialization category across the full dataset.

The analysis identifies therapeutic areas with significant market concentration risk using the Herfindahl-Hirschman Index (HHI). Two charts were generated: a horizontal bar chart showing HHI scores by therapeutic area (color-coded red/orange/green by risk level), and a bubble scatter plot comparing number of applicants vs. products with bubble size representing concentration. 6 therapeutic areas fall into the HIGH concentration category (HHI 2500), meaning they are dominated by very few applicants — posing the greatest market concentration risk. Additional areas fall into moderate and low concentration tiers.

The horizontal bar chart reveals which therapeutic areas have the fewest prequalified products, highlighting potential supply gaps. Areas with the lowest product counts appear at the top of the chart and represent the greatest risk for supply shortages. The visualization uses a color scale from red (fewest products) to green (most products), making it easy to spot underserved therapeutic areas at a glance.

Out of 669 total products, 96 (14.3%) have an alternative basis of listing. Two visualizations were generated: a pie chart showing the overall proportion of products with vs. without an alternative basis, and a bar chart breaking down these products by therapeutic area.

The analysis identifies which INN formulations (by dosage form and strength) attract the most competing applicants, signaling high market competition. A horizontal bar chart has been generated showing the top 20 most competitive formulations, color-coded by intensity using a red scale — darker red indicates more competitors.

The analysis identified which applicants have most accelerated their prequalification activity in recent years by comparing their output across two time periods. Two visualizations were generated: a grouped bar chart showing the top 10 accelerating applicants comparing their earlier vs. recent prequalification counts, and a line chart tracking the yearly prequalification trends for the top 5 accelerators over the past 7 years.

In the most recent 12 months (March 31, 2025 to March 31, 2026), a total of 32 products were prequalified from 20 unique applicants. Two charts and supporting data tables have been generated to help you explore these results visually.

The analysis produced visualizations and data tables showing how dosage forms are distributed across therapeutic areas, along with an innovation gap indicator. A stacked bar chart displays the top 10 therapeutic areas and their dosage form compositions, while a second chart ranks therapeutic areas by the number of unique dosage forms they use — serving as a proxy for innovation breadth.

Yes, there are seasonal and quarterly patterns in when products receive prequalification. Two bar charts and a heatmap were generated to visualize these trends. The first chart shows the distribution of prequalification approvals across all 12 months, while the second breaks it down by quarter (Q1–Q4). The heatmap provides a year-by-year view, showing how activity varied across quarters over time — making it easy to spot which periods consistently see more or fewer approvals.